Considering no significant differences of AUC_glucose levels at 7 weeks of age between the two groups (Figure 2), imeglimin treatment might contribute to the improvement of insulin sensitivity and/or the attenuation of the increasing insulin resistance. The gene discussed is INS; the disease is Insulin resistance.